ALXO Chart
See on advanced chart >
About
ALX Oncology Holdings Inc. was initially incorporated April 1, 2020. The Company is a clinical stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway and bridge the innate and...
Read More
- HighlightA clinical-stage immuno-oncology company that develops immuno-oncology therapies for the treatment of cancer
- ExchangeNASDAQ
- Listing Date07/17/2020
- Established Date04/01/2020
- Full-time Employees58
- Address323 Allerton Avenue South San Francisco California 94080
- Tel1-650-4667125
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Biotechnology
